You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 4, October 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Metabolic Alkalinization Therapy in Porphyria Cutanea Tarda

Harold O. Perry, MD; Milton G. Mullanax, MD; Stewart E. Wiegand, MD

Arch Dermatol. 1970;102(4):359-367.


Abstract

Metabolic alkalinization as therapy for porphyria cutanea tarda is easily accomplished and is without complications. Eight of ten patients with porphyria cutanea tarda treated by his means improved, as evidenced by a return of skin findings toward normal, reversal of abnormal results of liver function tests, and decreased urinary excretion of uroporphyrins. Five of these ten patients also abstained from further use of alcohol during treatment, and all five improved in contrast to a lessened response in five patients who continued to use alcohol. Thus, omission of alcohol as a treatment factor in itself must be considered in any therapeutic program. Although the exact role of iron metabolism in the etiology of porphyria cutanea tarda is not known, hemodynamics in patients judged to be improved showed decreased values for serum iron, a change that is similar to the changes reported when patients with porphyria cutanea tarda are treated by repeated phlebotomies. The two patients in the series who did no improve showed increased values for serum iron.



Author Affiliations

Rochester, Minn

From the Department of Dermatology, Mayo Clinic and the Mayo Graduate School of Medicine, University of Minnesota, Rochester. Dr. Wiegand is now with the US Public Health Service, Atlanta.


Footnotes

Aaccepted for publication June 22, 1970.

Read before the meeting of the American Dermatological Association, Boca Raton, Fla, March 24, 1970.

Reprint requests to Mayo Clinic, Rochester, Minn 55901 (Dr. Perry).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Erythropoietic Porphyria: Two Cases and the Results of Metabolic Alkalinization
Stretcher
Arch Dermatol 1977;113:1553-1557.
ABSTRACT  

Porphyria Cutanea Tarda: Report of a Case Treated With Phlebotomies and Supplemental Iron
Wechsler
Arch Dermatol 1972;105:432-433.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.